Lifecore Biomedical Inc

Lifecore Biomedical Inc

LNDC - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$331.53M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Lifecore Biomedical IncLifecore Biomedical Inc-3.4-298%2.9-
$8.80

Current Fair Value

0.5% upside

Undervalued by 0.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$331.53 Million
Enterprise Value$308.49 Million
Earnings per Share$0
Beta1.1
Outstanding Shares37,845,478

Return

Return on Equity297.75%ROE
Return on Assets-29.05%
Return on Invested Capital-0.50%

Valuation & Multiples

P/E Ratio-3.4P/E Ratio
PEG-1.13PEG
Price to Sales2.92Price to Sales
Price to Book Ratio-8.76Price to Book Ratio
Enterprise Value to Revenue2.6
Enterprise Value to EBIT-301.26
Enterprise Value to Net Income-5
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 5, 2026
EPS
-$0.19
Reported
Revenue
$34.17 M
Reported

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Landec Corp.

CEO: Albert Bolles

Lifecore Biomedical Insider Information FAQ

Stockcircle tracks 5 top investors with a current 13F position in Lifecore Biomedical. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.